AKT1 and B-cell chronic lymphocytic leukemia: Recent studies have identified that PI3K/AKT signaling could be limited by the suppression of the expression and activity of the inhibitory phosphatase SH2-containing-inositol-5′-phosphatase-1 (SHIP1) in CLL cells.